OMERS ADMINISTRATION Corp Acquires 3,690 Shares of Cardinal Health, Inc. $CAH

OMERS ADMINISTRATION Corp grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 19.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,835 shares of the company’s stock after purchasing an additional 3,690 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Cardinal Health were worth $4,825,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. University of Texas Texas AM Investment Management Co. bought a new position in Cardinal Health during the 4th quarter worth $26,000. Bank of Jackson Hole Trust acquired a new stake in shares of Cardinal Health during the 4th quarter worth $27,000. Jones Financial Companies Lllp grew its holdings in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares in the last quarter. Palladiem LLC bought a new position in shares of Cardinal Health in the fourth quarter worth $28,000. Finally, Indiana Trust & Investment Management Co acquired a new position in Cardinal Health in the first quarter valued at about $29,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

CAH stock opened at $227.96 on Monday. The stock has a market cap of $53.39 billion, a price-to-earnings ratio of 34.86, a P/E/G ratio of 1.11 and a beta of 0.49. The company has a 50 day simple moving average of $219.98 and a 200 day simple moving average of $214.50. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $243.21.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were given a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date was Wednesday, July 1st. Cardinal Health’s dividend payout ratio is 31.50%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a report on Friday, May 1st. UBS Group increased their price target on shares of Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Citigroup boosted their price objective on shares of Cardinal Health from $245.00 to $265.00 and gave the company a “buy” rating in a research report on Friday. Finally, TD Cowen raised their target price on Cardinal Health from $255.00 to $275.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus target price of $251.73.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.